Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

It’s Time to Start Talking about the Elephant in the Room

By Jonathan Goodman We at Dundee Goodman Merchant Partners have spent most of our working lives in the resource industry. Collectively we are money managers, geologists, engineers, mining operators, and natural resource/mining bankers. Moreover, all of us are person...
Research | April 5, 2023 |

Alphabet, Amazon, Enthusiast Gaming, Facebook - the big investment opportunity

The largest companies in the world all started small. The most expensive companies on the stock exchanges often have one thing in common, they are in online business. It is also hardly surprising that most of these companies are located in North America, a region with purchasi...
Mario Hose | April 23, 2020 |

BioNTech, CureVac, Valeo Pharma - COVID-19 wakes up the industry

In the past, people have accepted that it usually takes about ten years to get a vaccine on the market. Careful testing with proof of success is required for a preparation to receive approvals. Since COVID-19, the pressure to develop has increased dramatically and also the pot...
Mario Hose | September 1, 2020 |

Drone Delivery Canada Corp.

Drone Delivery Canada Corp. {“DDC”} (TSXV: FLT, OTC: TAKOF ) announced blockbuster news , it has entered into an agreement with Air Canada , whereby Air Canada Cargo (“ ACC ”) will market & sell DDC’s drone del...
Peter Epstein | June 10, 2019 |

New Rugged Handset Could Be A Game Changer For Siyata Mobile

First responders deserve better. Their traditional land mobile radio (LMR) setups are clunky, offer only low data speeds, and have limited coverage with dead zones that often slow down response times. Siyata Mobile Inc. ( NASDAQ: SYTA , Forum ) , with its push-to-talk ov...
Featured Submission | August 11, 2021 |

Puma Biotech Shares Up More Than 20% on Q2 Earnings and Breast Cancer Drug Sales

Shares in Puma Biotechnology are trading 20% higher today after the company released Q2/19 earnings and reported positive NERLYNX revenue growth. Biopharmaceutical company Puma Biotechnology Inc. (PBYI:NADSAQ) shares opened more than 20% higher to...
Streetwise Reports | August 14, 2019 |

Axsome Therapeutics Shares Open 82% Higher on Phase 3 MDD Trial Outcome

Axsome Therapeutics shares reached a new 52-week high price today after the company reported that its AXS-05 drug achieved primary endpoint in the GEMINI Phase 3 trial in Major Depressive Disorder. The firm indicated that the positive results support a New Drug Application fil...
Streetwise Reports | December 17, 2019 |

Vivus Shares Climb 50% Higher on sNDA Approval for Exocrine Pancreatic Insufficiency Drug

Shares of Vivus traded higher after the FDA approved the company's supplemental New Drug Application for an improved formulation of PANCREAZE® (pancrelipase) for use in the treatment of exocrine pancreatic insufficiency due to cystic fibrosis and other conditions. ...
Streetwise Reports | February 6, 2020 |

Alexion's Buyout of Portola Pharmaceuticals Gets Investors' Blood Flowing

Shares of Portola Pharmaceuticals traded 130% higher after the company reported that it has received an $18 per share buyout offer from Alexion Pharmaceuticals. Commercial-stage biotechnology company Portola Pharmaceuticals Inc. (PTLA:NASDAQ) , which focuse...
Streetwise Reports | May 6, 2020 |

Valeo Pharma Big Pharma Capabilities Presents Opportunity

Valeo Pharma Inc. is a Canadian specialty pharmaceutical company with big pharma capabilities while retaining small company flexibilities. Valeo is a fast-growing revenue generating company with a strong product portfolio and a robust product pipeline. Valeo Pharma In...
Fredrick William | May 15, 2020 |
1 2 3